On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Post-Surgery Atrial Fibrillation in Hospitalized Patients Is Associated with Increased Stroke Risk
Research suggests that patients who develop seemingly temporary cases of atrial fibrillation immediately after most types of surgery are dramatically more likely to suffer subsequent strokes.
Pennsylvania Implements New Guidelines for Treating Pain in the Emergency Department
The guidelines were developed as part of a multi-part plan to curb misuse, abuse, and diversion of opioid medication by preventing opioid medications from being inappropriately prescribed in the emergency department, and by reducing the overuse of emergency departments for pain relief.
Promising Developments in Fecal Microbiota Transplantation
Researchers have made several impressive advances in gastrointestinal medicine in recent years, including the use of fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infection. Following the success of that approach, researchers have been evaluating FMT for the treatment of other conditions, with one team recently conducting the first randomized controlled trial of FMT to treat inflammatory bowel disease (IBD).
Combination Hydrocodone Products Moving to Schedule II in October
August 22nd 2014Rescheduling hydrocodone combination products to the more-restrictive schedule II will impact clinicians and patients suffering with chronic pain, but will it have the desired effect on the misuse and abuse of these products?
Apremilast and the Future of Psoriatic Arthritis Treatment
August 21st 2014When it was approved by the FDA in March 2014, apremilast became the first oral medication approved for the treatment of psoriatic arthritis (PsA). Data from clinical trials showed it to be an effective option for patients, with a safer side effect profile than currently used PsA treatments.
The National Psoriasis Foundation Announces Ambitious New Programs and Initiatives
August 21st 2014The National Psoriasis Foundation (NPF) recently announced a number of new programs and a five-year strategic mission for the organization with initiatives that are designed to increase research and uncover new treatments for all forms of psoriasis and psoriatic disease.
Merck Looks to Become Bigger Player in Hepatitis C Market with Acquisition
Between developing its own pipeline of therapies for patients with hepatitis C and acquiring another company known for its work in this field, it looks like Merck is taking steps to be a larger player in HCV market.
Researchers Discover Molecular Changes Responsible for Skin Discoloration in Psoriasis
Many control psoriasis-ridden skin only to find traces of discolored patches in its wake. A study by the Milstein Medical Research Program at The Rockefeller University has uncovered the correlation between skin discoloration and psoriasis, providing opportunities of treatment for pigmentation changes within eczema and acne as well.
Acute Hepatitis C on the Rise Among Young People
August 19th 2014An emerging epidemic of acute hepatitis C threatens the country's younger population, which experienced a significant hike in the number of cases during a recent 6-year period, according to a compound study that looked at trends of the disease among youth.
Looking at Radiofrequency Ablation in Atrial Fibrillation
New research finds that people with atrial fibrillation (AF) who undergo radiofrequency ablation and maintain sinus rhythm are less likely than those who opt against the procedure to die of heart attack or heart failure.
Countries Affected by Ebola Urged to Screen All Travelers Seeking to Leave
As the number of people falling victim to the most recent outbreak of the Ebola Virus continues to rise past 1000, aid workers' focus has begun to shift to preventing the spread of Ebola beyond the African continent.